Abstract
Calcitonin gene-related peptide (CGRP) and related peptides may be involved in migraine pathogenesis. To understand their vasomotor role in the cerebral circulation, we performed two studies, a pressurized arteriography study of the middle cerebral artery (MCA) and a genuine closed cranial window (gCCW) in vivo study. Using the pressurized arteriography model rat MCAs were mounted on micropipettes, pressurized to 85 mmHg and luminally perfused. The diameter responses to luminally and abluminally applied rat-αCGRP, rat-βCGRP, amylin and adrenomedullin were compared with the resting diameter. Only abluminally applied CGRP induced dilation of the cerebral arteries; Emax for αCGRP and βCGRP were 35 ± 0.5% and 10.8 ± 0.2%. These responses were blocked by CGRP8-37. The gCCW model allowed videomicroscopic visualization of the pial vessels in anaesthetized rats. Changes in vessel diameter to intravenously administered αCGRP and βCGRP were compared with pre-infusion baseline. Intravenous infusion of αCGRP and βCGRP in the highest dose induced dilation of the cerebral cortical pial arteries/arterioles of 40.3 ± 7.5% and 49.1 ± 8.4%, respectively. However, this was probably secondary to a decrease in blood pressure of 44.8 ± 3.3 mmHg and 49.2 ± 3.3 mmHg. Our results suggest that CGRP receptors are probably functional on the smooth muscle cells and not on the endothelium of rat cerebral arteries.

This publication has 32 references indexed in Scilit: